-
1
-
-
0037905503
-
Diagnostic and therapeutic management of cancer of an unknown primary
-
Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990-2005.
-
(2003)
Eur J Cancer
, vol.39
, pp. 1990-2005
-
-
Pavlidis, N.1
Briasoulis, E.2
Hainsworth, J.3
Greco, F.A.4
-
3
-
-
84866558621
-
Carcinoma of Unknown Primary
-
Cavalli HH F, Kaye S, Amritage J, Pickard M, editors. 4th ed.
-
Daugaard G, Møller A, Petersen B. Carcinoma of Unknown Primary. In: Cavalli HH F, Kaye S, Amritage J, Pickard M, editors. Textbook of Medical Oncology. 4th ed. 2009. p. 313-22.
-
(2009)
Textbook of Medical Oncology
, pp. 313-322
-
-
Daugaard, G.1
Møller, A.2
Petersen, B.3
-
4
-
-
84856071488
-
Cancers of unknown primary origin: current perspectives and future therapeutic strategies
-
Stella GM, Senetta R, Cassenti A, Ronco M, Cassoni P. Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transl Med. 2012;10:12.
-
(2012)
J Transl Med
, vol.10
, pp. 12
-
-
Stella, G.M.1
Senetta, R.2
Cassenti, A.3
Ronco, M.4
Cassoni, P.5
-
5
-
-
79955016306
-
Circulating tumor cells: not all detected cells are bad and not all bad cells are detected
-
Wicha MS, Hayes DF. Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J Clin Oncol. 2011;29(12):1508-11.
-
(2011)
J Clin Oncol
, vol.29
, Issue.12
, pp. 1508-1511
-
-
Wicha, M.S.1
Hayes, D.F.2
-
6
-
-
21044436631
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP)
-
Briasoulis E, Tolis C, Bergh J, Pavlidis N. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Ann Oncol. 2005;16:75-6.
-
(2005)
Ann Oncol
, vol.16
, pp. 75-76
-
-
Briasoulis, E.1
Tolis, C.2
Bergh, J.3
Pavlidis, N.4
-
7
-
-
77956354810
-
Molecular signatures of thyroid follicular neoplasia
-
Borup R, Rossing M, Henao R, et al. Molecular signatures of thyroid follicular neoplasia. Endocr Relat Cancer. 2010;17(3):691-708.
-
(2010)
Endocr Relat Cancer
, vol.17
, Issue.3
, pp. 691-708
-
-
Borup, R.1
Rossing, M.2
Henao, R.3
-
8
-
-
0037316303
-
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
-
Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-93.
-
(2003)
Bioinformatics
, vol.19
, pp. 185-193
-
-
Bolstad, B.M.1
Irizarry, R.A.2
Astrand, M.3
Speed, T.P.4
-
9
-
-
41149168760
-
Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma
-
Ferreira BI, Alonso J, Carrillo J, Acquadro F, Largo C, Suela J, et al. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene. 2008;27:2084-90.
-
(2008)
Oncogene
, vol.27
, pp. 2084-2090
-
-
Ferreira, B.I.1
Alonso, J.2
Carrillo, J.3
Acquadro, F.4
Largo, C.5
Suela, J.6
-
10
-
-
33748286796
-
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
-
Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006;38:1043-8.
-
(2006)
Nat Genet
, vol.38
, pp. 1043-1048
-
-
Carter, S.L.1
Eklund, A.C.2
Kohane, I.S.3
Harris, L.N.4
Szallasi, Z.5
-
11
-
-
33746028189
-
A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin
-
Talantov D, Baden J, Jatkoe T, Hahn K, Yu J, Rajpurohit Y, et al. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn. 2006;8:320-9.
-
(2006)
J Mol Diagn
, vol.8
, pp. 320-329
-
-
Talantov, D.1
Baden, J.2
Jatkoe, T.3
Hahn, K.4
Yu, J.5
Rajpurohit, Y.6
-
12
-
-
20144377712
-
An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin
-
Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res. 2005;65:4031-40.
-
(2005)
Cancer Res
, vol.65
, pp. 4031-4040
-
-
Tothill, R.W.1
Kowalczyk, A.2
Rischin, D.3
Bousioutas, A.4
Haviv, I.5
Laar, R.K.6
-
13
-
-
33645779944
-
Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay
-
Ma XJ, Patel R, Wang X, Salunga R, Murage J, Desai R, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130:465-73.
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 465-473
-
-
Ma, X.J.1
Patel, R.2
Wang, X.3
Salunga, R.4
Murage, J.5
Desai, R.6
-
14
-
-
0035887459
-
Molecular classification of human carcinomas by use of gene expression signatures
-
Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001;61:7388-93.
-
(2001)
Cancer Res
, vol.61
, pp. 7388-7393
-
-
Su, A.I.1
Welsh, J.B.2
Sapinoso, L.M.3
Kern, S.G.4
Dimitrov, P.5
Lapp, H.6
-
15
-
-
1542574379
-
Multi-platform, multi-site, microarray-based human tumor classification
-
Bloom G, Yang IV, Boulware D, Kwong KY, Coppola D, Eschrich S, et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol. 2004;164:9-16.
-
(2004)
Am J Pathol
, vol.164
, pp. 9-16
-
-
Bloom, G.1
Yang, I.V.2
Boulware, D.3
Kwong, K.Y.4
Coppola, D.5
Eschrich, S.6
-
16
-
-
16244396701
-
The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center
-
Al-Brahim N, Ross C, Carter B, Chorneyko K. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center. Ann Diagn Pathol. 2005;9:77-80.
-
(2005)
Ann Diagn Pathol
, vol.9
, pp. 77-80
-
-
Al-Brahim, N.1
Ross, C.2
Carter, B.3
Chorneyko, K.4
-
17
-
-
79959224648
-
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary
-
Varadhachary GR, Spector Y, Abbruzzese JL, et al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res. 2011;17(12):4063-70.
-
(2011)
Clin Cancer Res
, vol.17
, Issue.12
, pp. 4063-4070
-
-
Varadhachary, G.R.1
Spector, Y.2
Abbruzzese, J.L.3
-
18
-
-
68249154794
-
Implementation of a novel microarray-based diagnostic test for cancer of unknown primary
-
van Laar RK, Ma XJ, de Jong D, Wehkamp D, Floore AN, Warmoes MO, et al. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary. Int J Cancer. 2009;125:1390-7.
-
(2009)
Int J Cancer
, vol.125
, pp. 1390-1397
-
-
Laar, R.K.1
Ma, X.J.2
Jong, D.3
Wehkamp, D.4
Floore, A.N.5
Warmoes, M.O.6
-
19
-
-
52449084470
-
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation
-
Varadhachary GR, Talantov D, Raber MN, Meng C, Hess KR, Jatkoe T, et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol. 2008;26:4442-8.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4442-4448
-
-
Varadhachary, G.R.1
Talantov, D.2
Raber, M.N.3
Meng, C.4
Hess, K.R.5
Jatkoe, T.6
-
20
-
-
75049085590
-
Comparison of histopathological and gene expression-based typing of cancer of unknown primary
-
Morawietz L, Floore A, Stork-Sloots L, et al. Comparison of histopathological and gene expression-based typing of cancer of unknown primary. Virchows Arch. 2010;456(1):23-9.
-
(2010)
Virchows Arch
, vol.456
, Issue.1
, pp. 23-29
-
-
Morawietz, L.1
Floore, A.2
Stork-Sloots, L.3
-
21
-
-
77149138310
-
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test
-
Monzon FA, Medeiros F, Lyons-Weiler M, et al. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test. Diagn Pathol. 2010;5:3.
-
(2010)
Diagn Pathol
, vol.5
, pp. 3
-
-
Monzon, F.A.1
Medeiros, F.2
Lyons-Weiler, M.3
-
22
-
-
52449118245
-
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary
-
Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, et al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol. 2008;26:4435-41.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4435-4441
-
-
Horlings, H.M.1
Laar, R.K.2
Kerst, J.M.3
Helgason, H.H.4
Wesseling, J.5
Hoeven, J.J.6
-
23
-
-
77952607898
-
Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction
-
Greco FA, Spigel DR, Yardley DA, et al. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist. 2010;15(5):500-6.
-
(2010)
Oncologist
, vol.15
, Issue.5
, pp. 500-506
-
-
Greco, F.A.1
Spigel, D.R.2
Yardley, D.A.3
-
24
-
-
84928234376
-
Molecular tumor profiling in the diagnosis of patients with carcinoma of unknown primary (CUP): Retrospective evaluation of the Tissue of Origin Test (Pathwork Diagnostics)
-
Hainsworth JD, Henner WD, Pillai R, and Greco FA. Molecular tumor profiling in the diagnosis of patients with carcinoma of unknown primary (CUP): Retrospective evaluation of the Tissue of Origin Test (Pathwork Diagnostics). J Clini Oncol 2010.
-
(2010)
J Clini Oncol
-
-
Hainsworth, J.D.1
Henner, W.D.2
Pillai, R.3
Greco, F.A.4
-
25
-
-
42149135334
-
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
-
Bridgewater J, van Laar R, Floore A, Van TVL. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer. 2008;98:1425-30.
-
(2008)
Br J Cancer
, vol.98
, pp. 1425-1430
-
-
Bridgewater, J.1
Laar, R.2
Floore, A.3
Van, T.V.L.4
-
26
-
-
34548497417
-
Switching benchmarks in cancer of unknown primary: from autopsy to microarray
-
Pentheroudakis G, Golfinopoulos V, Pavlidis N. Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer. 2007;43:2026-36.
-
(2007)
Eur J Cancer
, vol.43
, pp. 2026-2036
-
-
Pentheroudakis, G.1
Golfinopoulos, V.2
Pavlidis, N.3
-
27
-
-
84867130245
-
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases
-
Golfinopoulos V, Pentheroudakis G, Goussia A, Siozopoulou V, Bobos M, Krikelis D, et al. Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases. Ann Oncol. 2012;23:2725-30.
-
(2012)
Ann Oncol
, vol.23
, pp. 2725-2730
-
-
Golfinopoulos, V.1
Pentheroudakis, G.2
Goussia, A.3
Siozopoulou, V.4
Bobos, M.5
Krikelis, D.6
-
28
-
-
84863637373
-
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary
-
Krikelis D, Pentheroudakis G, Goussia A, Siozopoulou V, Bobos M, Petrakis D, et al. Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary. Clin Exp Metastasis. 2012;29:603-14.
-
(2012)
Clin Exp Metastasis
, vol.29
, pp. 603-614
-
-
Krikelis, D.1
Pentheroudakis, G.2
Goussia, A.3
Siozopoulou, V.4
Bobos, M.5
Petrakis, D.6
-
29
-
-
78650426144
-
MET mutations in cancers of unknown primary origin (CUPs)
-
Stella GM, Benvenuti S, Gramaglia D, Scarpa A, Tomezzoli A, Cassoni P, et al. MET mutations in cancers of unknown primary origin (CUPs). Hum Mutat. 2011;32:44-50.
-
(2011)
Hum Mutat
, vol.32
, pp. 44-50
-
-
Stella, G.M.1
Benvenuti, S.2
Gramaglia, D.3
Scarpa, A.4
Tomezzoli, A.5
Cassoni, P.6
-
30
-
-
0030837544
-
Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation
-
Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer. 1997;72:102-9.
-
(1997)
Int J Cancer
, vol.72
, pp. 102-109
-
-
Huang, R.P.1
Fan, Y.2
Belle, I.3
Niemeyer, C.4
Gottardis, M.M.5
Mercola, D.6
-
31
-
-
0034802945
-
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas
-
Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, et al. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res. 2001;7:2788-96.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2788-2796
-
-
Calogero, A.1
Arcella, A.2
Gregorio, G.3
Porcellini, A.4
Mercola, D.5
Liu, C.6
-
32
-
-
0028822914
-
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group
-
Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, et al. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene. 1995;11:1261-9.
-
(1995)
Oncogene
, vol.11
, pp. 1261-1269
-
-
Levin, W.J.1
Press, M.F.2
Gaynor, R.B.3
Sukhatme, V.P.4
Boone, T.C.5
Reissmann, P.T.6
-
33
-
-
84861851519
-
Cancer chromosomal instability: therapeutic and diagnostic challenges
-
McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012;13:528-38.
-
(2012)
EMBO Rep
, vol.13
, pp. 528-538
-
-
McGranahan, N.1
Burrell, R.A.2
Endesfelder, D.3
Novelli, M.R.4
Swanton, C.5
-
34
-
-
12244273951
-
Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management
-
Pantou D, Tsarouha H, Papadopoulou A, Mahaira L, Kyriazoglou I, Apostolikas N, et al. Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management. Neoplasia. 2003;5:23-31.
-
(2003)
Neoplasia
, vol.5
, pp. 23-31
-
-
Pantou, D.1
Tsarouha, H.2
Papadopoulou, A.3
Mahaira, L.4
Kyriazoglou, I.5
Apostolikas, N.6
-
35
-
-
84856019858
-
The DNA damage response and cancer therapy
-
Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287-94.
-
(2012)
Nature
, vol.481
, pp. 287-294
-
-
Lord, C.J.1
Ashworth, A.2
-
36
-
-
0037087627
-
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study
-
Greco FA, Burris 3rd HA, Litchy S, Barton JH, Bradof JE, Richards P, et al. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol. 2002;20:1651-6.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1651-1656
-
-
Greco, F.A.1
Burris, H.A.2
Litchy, S.3
Barton, J.H.4
Bradof, J.E.5
Richards, P.6
-
38
-
-
80054988946
-
Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes
-
Habermann JK, Bundgen NK, Gemoll T, Hautaniemi S, Lundgren C, Wangsa D, et al. Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Mol Cancer. 2011;10:132.
-
(2011)
Mol Cancer
, vol.10
, pp. 132
-
-
Habermann, J.K.1
Bundgen, N.K.2
Gemoll, T.3
Hautaniemi, S.4
Lundgren, C.5
Wangsa, D.6
-
39
-
-
63049102497
-
Parallel progression of primary tumours and metastases
-
Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9:302-12.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 302-312
-
-
Klein, C.A.1
|